Abstract
Chemotherapy is recommended for stage ⅢB/Ⅳ non-small cell lung cancer (NSCLC) treatment. The treatments for elderly patients with advanced NSCLC are mainly single-agent chemotherapy and platinum-based combination chemotherapy. However, elderly patients tolerate chemotherapy poorly because of age-related comorbidities. Therefore, the curative effect of elderly patients is relatively poorer as compared to their younger counterparts. Targeted therapy and immune therapy have become new research directions. It is important to select an appropriate program for elderly patients according to geriatric assessments. Key words: Carcinoma, non-small-cell lung; Aged; Antineoplastic protocols
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
